CD1D and infection: Since then, there have been more than a dozen α-GalCer analogues being described to date14,32–43, all of which are able to stimulate iNKT cells in the context of CD1d molecules, resulting in exerting activities against various infections, cancers and auto-immune diseases primarily in a mouse model.